148 related articles for article (PubMed ID: 34649939)
1. Increasing emergency department attendances in central London with methamphetamine toxicity and associated harms.
Harnett JT; Dargan PI; Dines AM; Archer JRH; Greene SL; Hunter LJ; Wood DM
Emerg Med J; 2022 Jun; 39(6):463-466. PubMed ID: 34649939
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication.
Galicia M; Dargan PI; Dines AM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Wood DM; Miró Ò;
Toxicol Lett; 2019 Oct; 314():37-42. PubMed ID: 31301370
[TBL] [Abstract][Full Text] [Related]
3. Trends in gamma-hydroxybutyrate-related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia.
Arunogiri S; Moayeri F; Crossin R; Killian JJ; Smith K; Scott D; Lubman DI
Addiction; 2020 Mar; 115(3):473-479. PubMed ID: 31618793
[TBL] [Abstract][Full Text] [Related]
4. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
[TBL] [Abstract][Full Text] [Related]
5. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.
Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM
Toxicol Lett; 2017 Aug; 277():84-91. PubMed ID: 28579487
[TBL] [Abstract][Full Text] [Related]
6. "Chemsex" and harm reduction need among gay men in South London.
Bourne A; Reid D; Hickson F; Torres-Rueda S; Steinberg P; Weatherburn P
Int J Drug Policy; 2015 Dec; 26(12):1171-6. PubMed ID: 26298332
[TBL] [Abstract][Full Text] [Related]
7. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
[TBL] [Abstract][Full Text] [Related]
8. Temporal differences in γ-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: a retrospective study.
Boyd JJ; Kuisma MJ; Randell TT
Scand J Trauma Resusc Emerg Med; 2012 Feb; 20():7. PubMed ID: 22296777
[TBL] [Abstract][Full Text] [Related]
9. A multicentre case series of analytically confirmed gamma-hydroxybutyrate intoxications in Western Australian emergency departments: Pre-hospital circumstances, co-detections and clinical outcomes.
Smith JL; Greene S; McCutcheon D; Weber C; Kotkis E; Soderstrom J; Douglas B; Lenton S; Grigg J; Dessauer P; Ezard N; Fatovich DM;
Drug Alcohol Rev; 2024 May; 43(4):984-996. PubMed ID: 38426636
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): implications for psychiatry services in the general hospital.
Choudhuri D; Cross S; Dargan PI; Wood DM; Ranjith G
Int J Psychiatry Clin Pract; 2013 Jun; 17(2):154-6. PubMed ID: 23485126
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of analytically confirmed gamma-hydroxybutyrate (GHB) positive patients in the emergency department: presentation, poly-drug use, disposition and impact on intensive care resource utilisation.
Stockham P; Partridge E; Alfred S; Boyle L; Camilleri A; Green H; Haustead D; Humphries M; Kostakis C; Mallon J
Clin Toxicol (Phila); 2023 Apr; 61(4):241-247. PubMed ID: 37129222
[TBL] [Abstract][Full Text] [Related]
12. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
Liakoni E; Walther F; Nickel CH; Liechti ME
Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H
Drug Alcohol Depend; 2006 Feb; 81(3):323-6. PubMed ID: 16143455
[TBL] [Abstract][Full Text] [Related]
14. Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021.
Harris O; Siefried KJ; Chiew A; Jamshidi N; Chung DT; Moore N; Nic Ionmhain U; Roberts DM; Ezard N; Brett J
Emerg Med Australas; 2024 Apr; ():. PubMed ID: 38558322
[TBL] [Abstract][Full Text] [Related]
15. Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex.
Busardò FP; Gottardi M; Tini A; Minutillo A; Sirignano A; Marinelli E; Zaami S
Curr Drug Metab; 2018; 19(13):1080-1085. PubMed ID: 30251602
[TBL] [Abstract][Full Text] [Related]
16. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.
Corkery JM; Loi B; Claridge H; Goodair C; Corazza O; Elliott S; Schifano F
Neurosci Biobehav Rev; 2015 Jun; 53():52-78. PubMed ID: 25843781
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of patients with analytically confirmed γ-hydroxybutyric acid/γ-butyrolactone (GHB/GBL)-related emergency department visits in Taiwan.
Weng TI; Chen LY; Chen JY; Chen GY; Mou CW; Chao YL; Fang CC
J Formos Med Assoc; 2021 Oct; 120(10):1914-1920. PubMed ID: 33893011
[TBL] [Abstract][Full Text] [Related]
18. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
McDaniel CH; Miotto KA
J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
[TBL] [Abstract][Full Text] [Related]
20. Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs.
Heier EC; Eyer F; Rabe C; Geith S; Dargan PI; Wood DM; Heyerdahl F; Dines AM; Giraudon I; Erik Hovda K; Yates C; Vallersnes OM; Miró Ò; Liechti ME; Zellner T;
Eur J Emerg Med; 2022 Aug; 29(4):291-300. PubMed ID: 35404314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
